Profound Medical Corp
TSX:PRN
Balance Sheet
Balance Sheet Decomposition
Profound Medical Corp
Profound Medical Corp
Balance Sheet
Profound Medical Corp
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & Cash Equivalents |
0
|
8
|
16
|
9
|
23
|
15
|
84
|
67
|
47
|
26
|
55
|
|
| Cash |
0
|
8
|
16
|
9
|
23
|
15
|
84
|
67
|
47
|
26
|
55
|
|
| Short-Term Investments |
0
|
7
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
1
|
0
|
0
|
4
|
2
|
3
|
7
|
1
|
6
|
7
|
7
|
|
| Accounts Receivables |
0
|
0
|
0
|
3
|
2
|
2
|
6
|
1
|
6
|
7
|
6
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
1
|
1
|
1
|
|
| Inventory |
0
|
0
|
0
|
1
|
3
|
4
|
5
|
7
|
8
|
7
|
6
|
|
| Other Current Assets |
1
|
0
|
1
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Total Current Assets |
2
|
15
|
17
|
14
|
28
|
23
|
98
|
77
|
62
|
42
|
69
|
|
| PP&E Net |
0
|
0
|
1
|
1
|
1
|
2
|
2
|
2
|
2
|
2
|
1
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
2
|
2
|
2
|
2
|
2
|
1
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
2
|
2
|
3
|
2
|
3
|
2
|
|
| Intangible Assets |
0
|
0
|
0
|
4
|
3
|
2
|
2
|
1
|
1
|
0
|
0
|
|
| Goodwill |
0
|
0
|
0
|
3
|
3
|
3
|
3
|
3
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Assets |
0
|
0
|
0
|
3
|
3
|
3
|
3
|
3
|
0
|
0
|
0
|
|
| Total Assets |
2
N/A
|
15
+582%
|
18
+15%
|
22
+26%
|
34
+54%
|
30
-12%
|
105
+248%
|
87
-17%
|
64
-26%
|
44
-32%
|
70
+60%
|
|
| Liabilities | ||||||||||||
| Accounts Payable |
1
|
1
|
1
|
4
|
3
|
3
|
3
|
3
|
2
|
3
|
1
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
|
| Short-Term Debt |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
2
|
4
|
1
|
4
|
0
|
0
|
1
|
2
|
2
|
|
| Other Current Liabilities |
30
|
0
|
0
|
1
|
2
|
1
|
1
|
1
|
1
|
1
|
0
|
|
| Total Current Liabilities |
33
|
1
|
4
|
9
|
6
|
8
|
5
|
4
|
4
|
6
|
7
|
|
| Long-Term Debt |
2
|
4
|
3
|
0
|
8
|
7
|
1
|
1
|
7
|
6
|
3
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
1
|
0
|
0
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
|
| Total Liabilities |
35
N/A
|
5
-85%
|
7
+26%
|
11
+66%
|
15
+34%
|
16
+7%
|
7
-54%
|
6
-15%
|
12
+102%
|
13
+3%
|
10
-23%
|
|
| Equity | ||||||||||||
| Common Stock |
0
|
48
|
62
|
78
|
89
|
100
|
212
|
220
|
206
|
217
|
282
|
|
| Retained Earnings |
33
|
40
|
53
|
72
|
81
|
108
|
130
|
161
|
189
|
218
|
245
|
|
| Additional Paid In Capital |
1
|
1
|
2
|
5
|
12
|
15
|
11
|
17
|
19
|
20
|
21
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
7
|
5
|
5
|
17
|
12
|
3
|
|
| Total Equity |
33
N/A
|
10
N/A
|
11
+9%
|
11
+2%
|
20
+74%
|
14
-26%
|
97
+577%
|
81
-17%
|
52
-35%
|
31
-40%
|
60
+94%
|
|
| Total Liabilities & Equity |
2
N/A
|
15
+582%
|
18
+15%
|
22
+26%
|
34
+54%
|
30
-12%
|
105
+248%
|
87
-17%
|
64
-26%
|
44
-32%
|
70
+60%
|
|
| Shares Outstanding | ||||||||||||
| Common Shares Outstanding |
0
|
4
|
6
|
7
|
11
|
12
|
20
|
21
|
21
|
21
|
30
|
|